For example, utilizing a CRISPR/Cas9 approach to disrupt A2AR on CAR-T cells in culture led to an increase in IFNγ, TNFα, JAK/STAT pathway genes, CAR-T cell survival, and control of tumor burden in a murine breast cancer model [147]. Here, IFNG is linked to neoplasm.